Compare CCL & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCL | VEEV |
|---|---|---|
| Founded | 1972 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.0B | 44.8B |
| IPO Year | 1994 | 2013 |
| Metric | CCL | VEEV |
|---|---|---|
| Price | $22.11 | $266.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 25 |
| Target Price | $33.99 | ★ $280.42 |
| AVG Volume (30 Days) | ★ 17.9M | 1.6M |
| Earning Date | 03-27-2026 | 05-27-2026 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | ★ 40.28 | 25.93 |
| EPS | 0.57 | ★ 3.22 |
| Revenue | ★ $18,881,000,000.00 | $1,104,081,000.00 |
| Revenue This Year | $5.69 | $14.42 |
| Revenue Next Year | $3.52 | $12.17 |
| P/E Ratio | ★ $39.91 | $81.49 |
| Revenue Growth | 7.83 | ★ 28.05 |
| 52 Week Low | $22.28 | $148.05 |
| 52 Week High | $34.03 | $310.50 |
| Indicator | CCL | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 28.80 | 58.79 |
| Support Level | N/A | $151.71 |
| Resistance Level | $28.22 | $296.24 |
| Average True Range (ATR) | 0.60 | 8.62 |
| MACD | -0.16 | -3.30 |
| Stochastic Oscillator | 9.54 | 46.22 |
Carnival is the largest global cruise company, with nearly 100 ships in service. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It recently folded its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted nearly 14 million guests in 2025.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.